Trovagene, inc. (TROV)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Revenues [Abstract]
Total revenues

244

378

-

-

-

-

-

-

-

Royalties

-

-

285

258

274

270

259

175

227

Milestone fees

-

-

-

-

-

-

-

150

0

License fees

-

-

-

-

-

10

0

125

30

Services and other

-

-

219

-

13

0

0

-

-

Diagnostic services

-

-

-

86

-

-

-

-

-

Clinical research services

-

-

-

36

24

0

0

-

-

Total revenues

-

-

505

381

312

280

259

450

257

Costs and expenses:
Cost of revenue

0

597

1,811

1,730

629

15

-

-

-

Research and development

11,162

8,164

7,882

15,006

10,593

6,664

3,947

1,920

910

Selling and marketing

-

-

-

11,523

6,443

2,734

1,530

506

-

Selling, general and administrative

5,760

8,005

14,232

-

-

-

-

-

2,323

General and administrative

-

-

-

11,475

7,919

5,810

5,472

2,872

-

Restructuring charges

0

664

2,174

790

0

0

-

-

-

Total operating expenses

16,923

17,431

26,101

40,526

25,586

15,225

10,949

5,299

-

Total operating expenses

-

-

-

-

-

-

-

-

3,234

Loss from operations

-16,678

-17,053

-25,595

-40,145

-25,273

-14,945

-10,690

-4,849

-2,976

Interest income

234

219

147

298

-

-

-

-

-

Interest income

-

-

-

-

-

-

3

-

0

Interest expense

0

25

1,033

1,674

-

-

17

-

56

Other gain (loss), net

1

-236

-170

-

-2

24

-22

-

-

Gain on extinguishment of debt

0

17

-1,655

0

-

-

-

-

623

Net interest income (expense)

-

-

-

-

-1,468

-831

-

-

-

Gain on disposal of equipment

-

-

-

-

-

-

-

4

-

Gain (loss) from change in fair value of derivative financial instruments—warrants

28

617

3,401

2,462

-726

1,425

-1,084

-6,720

170

Other income (expense), net

-

-

-

-144

-

-

-

-

-

Net loss

-16,414

-16,461

-24,906

-39,203

-27,471

-14,325

-11,810

-11,565

-2,239

Preferred stock dividend payable on Series A Convertible Preferred Stock

24

24

24

24

24

23

29

38

38

Deemed dividend recognized for beneficial conversion features of Convertible Preferred Stock issuance

-

-

0

-

-

-

-

-

-

Net loss attributable to common stockholders

-16,706

-19,254

-24,930

-39,227

-27,495

-14,348

-11,840

-11,604

-2,277

Net loss per common share - basic (in USD per share)

-

-

-51.76

-15.60

-1.05

-0.76

-0.70

-0.89

-

Net loss per common share - diluted (in USD per share)

-

-

-51.76

-15.55

-1.21

-0.88

-0.70

-0.89

-

Weighted Average Number of Shares Outstanding, Basic

-

-

481

2,514

26,201

18,904

16,978

13,066

-

Weighted Average Number of Shares Outstanding, Diluted

-

-

481

2,523

26,452

19,071

16,978

13,066

-

Net loss per common share - basic and diluted (in dollars per share)

-2.80

-8.26

-

-

-

-

-

-

-0.23

Weighted-average shares outstanding - basic and diluted (in shares)

5,973

2,330

-

-

-

-

-

-

9,711

Royalties
Royalties

243

250

-

-

-

-

-

-

-

Services
Services

1

127

-

-

-

-

-

-

-

Series B Convertible Preferred Stock
Deemed dividend recognized on beneficial conversion features of Convertible Preferred Stock issuance

0

2,769

-

-

-

-

-

-

-

Series C Convertible Preferred Stock
Deemed dividend recognized on beneficial conversion features of Convertible Preferred Stock issuance

268

0

-

-

-

-

-

-

-